AcuScreen, Qualcomm Tricorder XPRIZE Winner, Can Help Address Global Crisis of 3 Million Undiagnosed Tuberculosis Cases Medical Device Investing
COMPASS Pathways to launch phase II trial of COMP360 psilocybin therapy for post-traumatic stress disorder Psychedelics Investing
Bristol Myers Squibb Data at ACR Convergence 2021 Illustrate Scientific Advances for Immune-Mediated Rheumatic Diseases Pharmaceutical Investing
Aurinia Reports Third Quarter and Nine Months 2021 Financial Results and Company Updates Pharmaceutical Investing
FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of BMY, HNST and HYZN Pharmaceutical Investing
Goodness Growth Holdings Announces Planned Divestiture of Arizona Dispensary License Cannabis Investing News
Cardiol Therapeutics Files Preliminary Prospectus Supplement for Proposed Public Offering of Units Pharmaceutical Investing
OPDIVO® Receives Two New Health Canada Approvals for: Use with Chemotherapy for the Treatment for Patients with HER2 Negative Advanced or Metastatic Gastric, Gastroesophageal Junction or Esophageal Adenocarcinoma Cancers; Use as Monotherapy for the Adjuvant Treatment for Patients with Completely Resected Esophageal or Gastroesophageal Junction Cancers Pharmaceutical Investing
